Single-cell Analysis Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Cancer, Stem Cell), By Workflow (Downstream Analysis, Data Analysis), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Single-cell Analysis Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Cancer, Stem Cell), By Workflow (Downstream Analysis, Data Analysis), By End-use, By Region, And Segment Forecasts, 2024 - 2030


Single-cell Analysis Market Growth & Trends

The global single-cell analysis market size was estimated at USD 13.69 billion in 2030 and is projected to grow at a CAGR of 18.7% from 2024 to 2030. Technology advances, expanding applications in cancer research, and higher government funding for cell-based research are the main drivers of the market. In addition, the market is advancing as a result of the COVID-19 pandemic. For instance, in January 2021, according to the American Journal of Physiology, variations in the peripheral blood mononuclear cellular profiles of COVID-19-infected patients were examined by using single-cell analysis (SEA) through mass cytometry, which supplemented the industry growth.

Government agencies around the world have increased funding for vaccine development and production in response to the ongoing pandemic's economic and social costs, which has increased the use of SEA tools for COVID-19 research. In order to develop better prognostic and diagnostic indicators and establish suitable therapeutic approaches for people with serious disease presentation, it is essential to know the host immune response throughout pathogenicity. Therefore, the market is positively impacted by COVID-19 because single-cell analysis helps in the assessment of peripheral immune function in the disease and makes new contributions to the study of the disease's pathophysiology and treatment possibilities.

Single-cell technology aids in the molecular level examination of pathways and processes as well as the assessment of cellular heterogeneity. This technology is developing rapidly with uses in oncology, immunology, and other fields. Further, the development of sophisticated tools that make transcriptomic and proteomic processes simpler is boosting the use of SEA methods. Researchers are now able to comprehensively examine previously unstudied uncommon cell types owing to developments in scRNA sequencing (scRNAseq). The application of single-cell genomic/transcriptomic analysis in the biomedical area has been greatly expanded by the development of microfluidics technology. Furthermore, cell dissociation and tissue digestion have been adapted for a large range of microfluidic devices, which have increased the adoption of SEA technology and further boosted industry growth.

The rising investment flow in R&D in this space is reflected in the rising number of research publications. For instance, in April 2020, A USD 2 million funding round was headed by the venture capital firm i&i Biotech Fund for Sampling Human, a young life science technology startup that has created a diagnostic platform that uses genetically modified cells to examine other cells in their environment (i&i Bio). Further, R&D and business growth will all be advanced by the investment. Moreover, these expenditures indicate a better growth opportunity for this market because R&D efforts serve as the foundation for innovation. Additionally, scientists are analyzing geographic variability in gene expression profiles at the single-cell level, which is expected to increase the demand for consumables and equipment for analysis, thus propelling the industry's growth.

Single-cell Analysis Market Report Highlights
  • By product, the consumables segment held the largest revenue share in 2021. The segment is anticipated to be driven by the extensive use of consumables in genetic research, exosome analysis, and RNA and DNA isolation
  • Based on application, the cancer segment captured the largest revenue share in 2022. The segment is being driven by single-cell analysis, which has shown to be successful for earlier cancer diagnoses. These techniques make it simple to determine cell kinds, mutation rates, and growth settings
  • In terms of workflow, the single cell isolation and library preparation segment held the largest revenue share in 2022. Increasing research using single-cell analysis is anticipated to boost the revenue growth
  • Based on end-user, the academic and research laboratories segment held the largest revenue share in 2022. The widespread use of different SEA techniques in research settings has been influenced by a sizeable number of ongoing research projects at academic institutions that use SEA assays
  • North America held the largest revenue share in 2022. This is mostly attributed to the occurrence of significant market participants and rising R&D spending and federal assistance
  • Asia Pacific is expected to grow at the highest rate over the forecast period owing to factors such as the increasing prevalence of target diseases, growing aging population, and rising single cell technology adoption
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Workflow
1.2.4. End-use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Single-cell Analysis Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Expanding application scope
3.2.1.1.1. Disease diagnosis
3.2.1.1.2. Drug discovery & development
3.2.1.2. Lucrative growth of sequencing technology
3.2.1.3. Technological innovations in single-cell analysis and cell isolation
3.2.1.4. Rising incidence of cancer
3.2.2. Market restraint analysis
3.2.2.1. High cost of instruments
3.2.2.2. Higher penetration of conventional mode of gene & cell analysis
3.3. Single-cell Analysis Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Single-cell Analysis Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Single-cell Analysis Market Product Movement Analysis
4.3. Global Single-cell Analysis Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Consumables
4.4.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Reagents
4.4.2.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Assay Kits
4.4.3.1. Assay kits market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Instrument
4.5.1. Instrument market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Microscope
4.5.2.1. Microscope market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Hemocytometers
4.5.3.1. Hemocytometers market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Flow cytometers
4.5.4.1. Flow cytometers market estimates and forecasts 2018 to 2030 (USD Million)
4.5.5. Next Generation Sequencing Systems
4.5.5.1. Next generation sequencing systems market estimates and forecasts 2018 to 2030 (USD Million)
4.5.6. PCR
4.5.6.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
4.5.7. High Content Screening Systems
4.5.7.1. High content screening systems market estimates and forecasts 2018 to 2030 (USD Million)
4.5.8. Cell Microarrays
4.5.8.1. Cell microarrays market estimates and forecasts 2018 to 2030 (USD Million)
4.5.9. Single Live Cell Imaging
4.5.9.1. Single live cell imaging market estimates and forecasts 2018 to 2030 (USD Million)
4.5.10. Automated Cell Counters
4.5.10.1. Automated cell counters market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Single-cell Analysis Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Single-cell Analysis Market Application Movement Analysis
5.3. Global Single-cell Analysis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cancer
5.4.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Immunology
5.5.1. Immunology market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Neurology
5.6.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Stem Cell
5.7.1. Stem cell market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Non-invasive Prenatal Diagnosis
5.8.1. Non-invasive prenatal diagnosis market estimates and forecasts 2018 to 2030 (USD Million)
5.9. In-vitro Fertilisation
5.9.1. In-vitro fertilisation market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Heart Cells
5.10.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
5.11. Skeletal and Muscle Cells
5.11.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
5.12. Others
5.12.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Single-cell Analysis Market: Workflow Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Single-cell Analysis Market Workflow Movement Analysis
6.3. Global Single-cell Analysis Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
6.4. Single Cell Isolation & Library Preparation
6.4.1. Single cell isolation & library preparation market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Downstream Analysis
6.5.1. Downstream analysis market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Data Analysis
6.6.1. Data analysis market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Single-cell Analysis Market: End-Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Single-cell Analysis Market End-Use Movement Analysis
7.3. Global Single-cell Analysis Market Size & Trend Analysis, by End-Use, 2018 to 2030 (USD Million)
7.4. Academic and Research Laboratories
7.4.1. Academic and research laboratories market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Biotechnology and Pharmaceutical Companies
7.5.1. Biotechnology and pharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Hospitals and Diagnostic Laboratories
7.6.1. Hospitals and diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Others
7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Single-cell Analysis Market: Regional Estimates & Trend Analysis By Product, Application, Workflow & End-use.
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.9. Denmark
8.5.9.1. Key country dynamics
8.5.9.2. Regulatory framework
8.5.9.3. Competitive scenario
8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. Mexico
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Argentina
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Competitive scenario
8.7.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. Middle East & Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Regulatory framework
8.8.5.3. Competitive scenario
8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Financial Performance
9.2. Participant Categorization
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific, Inc
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. QIAGEN NV
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Bio-Rad Laboratories, Inc.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Illumina, Inc.
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Merck KGaA
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Becton, Dickinson & Company (BD)
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Fluidigm Corporation (Standard BioTools Inc.)
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. 10x Genomics, Inc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. BGI
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Novogene Co, Ltd.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings